Works matching DE "INTRANASAL administration"
Results: 995
Zavegepant nasal spray in the acute treatment of migraine: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 11, doi. 10.1007/s40267-024-01130-4
- By:
- Publication type:
- Article
Adis summary of research: Efficacy and safety of esketamine nasal spray in patients with treatment-resistant depression who completed a second induction period: analysis of the ongoing SUSTAIN-3 study.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 383, doi. 10.1007/s40267-024-01106-4
- By:
- Publication type:
- Article
Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 257, doi. 10.1007/s00228-022-03431-x
- By:
- Publication type:
- Article
Neffy, First Needle-Free Epinephrine, Fills a Deep Need for Patients, says Allergy Expert.
- Published in:
- Patient Care (Online), 2024, p. 11
- By:
- Publication type:
- Article
Acylation of the Rat Brain Proteins is Affected by the Inhibition of Pyruvate Dehydrogenase in vivo.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 1, p. 105, doi. 10.1134/S0006297923010091
- By:
- Publication type:
- Article
Development of Glycerosomal pH Triggered In Situ Gelling System to Ameliorate the Nasal Delivery of Sulpiride for Pediatric Psychosis.
- Published in:
- Gels (2310-2861), 2024, v. 10, n. 9, p. 608, doi. 10.3390/gels10090608
- By:
- Publication type:
- Article
Comparative Study of TPGS and Soluplus Polymeric Micelles Embedded in Poloxamer 407 In Situ Gels for Intranasal Administration.
- Published in:
- Gels (2310-2861), 2024, v. 10, n. 8, p. 521, doi. 10.3390/gels10080521
- By:
- Publication type:
- Article
Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting.
- Published in:
- Gels (2310-2861), 2023, v. 9, n. 2, p. 130, doi. 10.3390/gels9020130
- By:
- Publication type:
- Article
The effect of hypertonic alkaline nasal irrigation on nasal wound healing in an experimental animal model.
- Published in:
- Praxis of Otorhinolaryngology / Kulak Burun Boğaz Uygulamaları, 2022, v. 10, n. 3, p. 87, doi. 10.5606/kbbu.2022.26214
- By:
- Publication type:
- Article
Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer's disease by administration through an intranasal route.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07599-7
- By:
- Publication type:
- Article
Pharmacokinetics of Mephedrone and Its Metabolites in Whole Blood and Plasma after Controlled Intranasal Administration to Healthy Human Volunteers.
- Published in:
- Journal of Analytical Toxicology, 2021, v. 45, n. 7, p. 730, doi. 10.1093/jat/bkaa134
- By:
- Publication type:
- Article
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00798-9
- By:
- Publication type:
- Article
The effect of intranasal administration of an IL-1b antagonist (RAIL) on the state of the nitroxydergic system of the brain during modeling of acute cerebrovascular accident.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 3, p. 665, doi. 10.3897/pharmacia.68.e71243
- By:
- Publication type:
- Article
NEBULIZED INTRANASAL SCOPOLAMINE MAY PROVIDE RAPID RELIEF FOR SPACE MOTION SICKNESS.
- Published in:
- Aerospace Medicine & Human Performance, 2024, v. 95, n. 8, p. 565
- By:
- Publication type:
- Article
Intranasal Scopolamine for Motion Sickness.
- Published in:
- Aerospace Medicine & Human Performance, 2019, v. 90, n. 11, p. 917, doi. 10.3357/AMHP.5456.2019
- By:
- Publication type:
- Article
Investigation of the optimal method of oxygen administration with simultaneous use of a surgical mask in postoperative patients: a randomized cross-over study.
- Published in:
- JA Clinical Reports, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40981-024-00741-0
- By:
- Publication type:
- Article
Esketamine and Hopelessness: Very Short-Term Effects.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Clinical suitability of intranasal delivery of M2 macrophage soluble factors in patients with post-COVID olfactory disorders.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Human type 2 macrophages biologically active soluble products in the editing of stress-induced depressive-like behavior.
- Published in:
- European Psychiatry, 2021, v. 64, p. S764, doi. 10.1192/j.eurpsy.2021.2023
- By:
- Publication type:
- Article
The role of intranasal esketamine in treatment-resistant depression.
- Published in:
- European Psychiatry, 2021, v. 64, p. S478, doi. 10.1192/j.eurpsy.2021.1278
- By:
- Publication type:
- Article
Neuropeptide y and neuropeptide s in major depressive disorder and post-traumatic stress disorder: Preclinical andclinical studies.
- Published in:
- European Psychiatry, 2021, v. 64, p. S21, doi. 10.1192/j.eurpsy.2021.80
- By:
- Publication type:
- Article
Treatment of Mouse Infants with Amoxicillin, but Not the Human Milk-Derived Antimicrobial HAMLET, Impairs Lung Th17 Responses.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 423, doi. 10.3390/antibiotics12020423
- By:
- Publication type:
- Article
Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 6, p. 749, doi. 10.3390/antibiotics11060749
- By:
- Publication type:
- Article
Effect of Inoculation Volume on a Mouse Model of Influenza Virus Infected with the Same Viral Load.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 173, doi. 10.3390/vaccines13020173
- By:
- Publication type:
- Article
Effect of Inoculation Volume on a Mouse Model of Influenza Virus Infected with the Same Viral Load.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 173, doi. 10.3390/vaccines13020173
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1401, doi. 10.3390/vaccines12121401
- By:
- Publication type:
- Article
Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1171, doi. 10.3390/vaccines12101171
- By:
- Publication type:
- Article
Enhanced Systemic and Mucosal Immune Responses to Haemophilus parasuis by Intranasal Administration of Lactic-Co-Glycolic Acid Microspheres.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1103, doi. 10.3390/vaccines12101103
- By:
- Publication type:
- Article
Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8 + T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1022, doi. 10.3390/vaccines12091022
- By:
- Publication type:
- Article
Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 902, doi. 10.3390/vaccines12080902
- By:
- Publication type:
- Article
Immunogenicity and Protective Efficacy of a Single Intranasal Dose Vectored Vaccine Based on Sendai Virus (Moscow Strain) against SARS-CoV-2 Variant of Concern.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 783, doi. 10.3390/vaccines12070783
- By:
- Publication type:
- Article
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 491, doi. 10.3390/vaccines12050491
- By:
- Publication type:
- Article
Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 449, doi. 10.3390/vaccines12050449
- By:
- Publication type:
- Article
Mucosal Immunization with Spore-Based Vaccines against Mannheimia haemolytica Enhances Antigen-Specific Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 375, doi. 10.3390/vaccines12040375
- By:
- Publication type:
- Article
Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 343, doi. 10.3390/vaccines12040343
- By:
- Publication type:
- Article
Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 5, doi. 10.3390/vaccines12010005
- By:
- Publication type:
- Article
Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1732, doi. 10.3390/vaccines11111732
- By:
- Publication type:
- Article
The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 305, doi. 10.3390/vaccines11020305
- By:
- Publication type:
- Article
Attitude towards Intranasal Vaccines and Psychological Determinants: Effects on the General Population in Northern Italy.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 138, doi. 10.3390/vaccines11010138
- By:
- Publication type:
- Article
The Role of Needle Fear in Pediatric Flu Vaccine Hesitancy: A Cross-Sectional Study in Bologna Metropolitan Area.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1388, doi. 10.3390/vaccines10091388
- By:
- Publication type:
- Article
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071060
- By:
- Publication type:
- Article
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1388, doi. 10.3390/vaccines9121388
- By:
- Publication type:
- Article
Enhancement of the Local CD8 + T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1273, doi. 10.3390/vaccines9111273
- By:
- Publication type:
- Article
Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1177, doi. 10.3390/vaccines9101177
- By:
- Publication type:
- Article
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 881, doi. 10.3390/vaccines9080881
- By:
- Publication type:
- Article
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 768, doi. 10.3390/vaccines9070768
- By:
- Publication type:
- Article
Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 589, doi. 10.3390/vaccines9060589
- By:
- Publication type:
- Article
Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 499, doi. 10.3390/vaccines9050499
- By:
- Publication type:
- Article
Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 234, doi. 10.3390/vaccines9030234
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 224, doi. 10.3390/vaccines9030224
- By:
- Publication type:
- Article